Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1514897
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1514897
Nasal Vaccines Market, By Vaccine Type, By Delivery Method, By Distribution, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
PUBLISHED:
PAGES: 357 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Nasal Vaccines Market size was valued at USD 418.9 million in 2023, expanding at a CAGR of 8.56% from 2024 to 2032.
Nasal vaccines, delivered as a spray or mist through the nose, offer a needle-free and potentially more efficient way to trigger immune responses. The growing preference for needle-free vaccinations, particularly among children and needle-phobic individuals. Additionally, nasal vaccines' ability to induce mucosal immunity, potentially providing better protection against respiratory illnesses, fuels market growth. However, challenges like ensuring the stability of the vaccine and navigating stringent regulatory pathways may act as restraints. Exciting opportunities lie in advancements in delivery systems for improved efficacy and the development of vaccines for various respiratory diseases, including COVID-19.
Nasal Vaccines Market- Market Dynamics
Rising prevalence of respiratory infections propelling the market growth
The increasing prevalence of respiratory infections is fueling the growth of the nasal vaccine market, as this technology offers a needle-free alternative to immunization. According to the World Health Organization, respiratory infections account for a significant portion of global mortality, with influenza alone causing an estimated 290,000 to 650,000 deaths annually. This burden, coupled with a growing preference for needle-free vaccinations, is driving the nasal vaccine market. For instance, a recent study published in a reputable medical journal demonstrated that a nasal vaccine for RSV (respiratory syncytial virus) proved effective in protecting infants, highlighting the potential of this. As the fight against respiratory illnesses continues, nasal vaccines are poised to play a more prominent role.
Nasal Vaccines Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.56% over the forecast period (2024-2032)
Based on Vaccine Type segmentation, Live attenuated vaccines were predicted to show maximum market share in the year 2023
Based on Delivery Method segmentation, Spray was the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
Nasal Vaccines Market- Segmentation Analysis:
The Global Nasal Vaccines Market is segmented based on Vaccine Type, Delivery Method, Distribution, and Region.
The market is divided into five categories based on Vaccine Type: Live attenuated vaccines, Inactivated vaccines, Subunit, Recombinant, and Conjugate Vaccines. Live attenuated vaccines, weakened versions of the virus that stimulate a strong immune response, are expected to see significant growth due to their potential for long-lasting immunity. However, recombinant vaccines, engineered to contain specific antigens that trigger a targeted immune response, are also gaining traction due to their safety profile and ease of production.
The market is divided into two categories based on the Delivery Method: Spray and Drop. Spray is anticipated to be the dominant delivery method in the nasal vaccine market. Sprays offer greater ease of administration, particularly for children and those with needle aversion, and ensure a wider distribution of the vaccine within the nasal cavity for optimal immune response.
Nasal Vaccines Market- Geographical Insights
North America currently holds a significant share due to established research infrastructure, government funding for vaccine development, and a high adoption rate of new technologies. However, the Asia Pacific region is expected to witness the fastest growth. This is driven by factors like a large and growing population susceptible to respiratory illnesses, rising disposable income, and government initiatives promoting childhood immunization programs. Europe presents a steady market with a focus on robust regulatory frameworks and advanced vaccine research. Emerging markets in Latin America and the Middle East & Africa offer promising potential due to a growing focus on improving public health infrastructure and increasing awareness of vaccination benefits. Manufacturers who can navigate regional regulatory requirements, address affordability concerns, and tailor their delivery systems to suit local needs will be well-positioned to tap into this expanding market.
Nasal Vaccines Market- Competitive Landscape:
Pharmaceutical giants like AstraZeneca and Sanofi Pasteur hold a strong presence due to their experience in vaccine development and global distribution networks. However, smaller biotechnology companies are making significant strides with innovative delivery systems and niche vaccines targeting specific respiratory illnesses. Additionally, academic institutions and research centers play a crucial role in developing novel nasal vaccine platforms. Strategic collaborations between these entities are becoming increasingly common, leveraging combined expertise to accelerate research and development. Mergers and acquisitions are also a potential factor, with established players seeking to expand their vaccine portfolios or gain access to promising new technologies. This competitive landscape necessitates a focus on innovation, strategic partnerships, and a commitment to addressing unmet medical needs to gain a foothold in the growing nasal vaccine market.
Recent Developments:
In January 2023, Bharat Biotech International Limited (BBIL) and Biotechnology Industry Research Assistance (BIRAC) developed iNNCOVACC, the world's first intranasal COVID-19 vaccine to receive approval for the primary 2-dose schedule and as a heterologous booster dose.
In October 2023, Mylab and Serum Institute of India launched Nasovac S4, India's first needle-free nasal influenza vaccine. The vaccine contains four influenza virus strains and is available through healthcare providers and clinics across India, aligning with WHO recommendations
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NASAL VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Altimmune Inc.
AstraZeneca PLC
Bharat Biotech International Limited
BioDiem, Inc.
CanSino Biopharmaceuticals Inc.
GlaxoSmithKline plc
Iovance Biotherapeutics, Inc.
Meda Pharma GmbH
MeDiVac, Inc.
Pfizer Inc.
Sanofi S.A.
Seqirus Holdings Pty Ltd
Serum Institute of India Pvt. Ltd.
TransBio Inc.
Vaxlive Inc.
Others
GLOBAL NASAL VACCINES MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019 - 2032
- Live attenuated vaccines
- Inactivated vaccines
- Subunit
- Recombinant
- Conjugate Vaccines
GLOBAL NASAL VACCINES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032
- Spray
- Drop
GLOBAL NASAL VACCINES MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032
- Public
- Private
GLOBAL NASAL VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV3027
Table of Contents
1. Nasal Vaccines Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Nasal Vaccines Market Snippet by Vaccine Type
- 2.1.2. Nasal Vaccines Market Snippet by Delivery Method
- 2.1.3. Nasal Vaccines Market Snippet by Distribution
- 2.1.4. Nasal Vaccines Market Snippet by Country
- 2.1.5. Nasal Vaccines Market Snippet by Region
- 2.2. Competitive Insights
3. Nasal Vaccines Key Market Trends
- 3.1. Nasal Vaccines Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Nasal Vaccines Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Nasal Vaccines Market Opportunities
- 3.4. Nasal Vaccines Market Future Trends
4. Nasal Vaccines Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Nasal Vaccines Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Nasal Vaccines Market Landscape
- 6.1. Nasal Vaccines Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Nasal Vaccines Market - By Vaccine Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Vaccine Type, 2023 & 2032 (%)
- 7.1.2. Live attenuated vaccines
- 7.1.3. Inactivated vaccines
- 7.1.4. Subunit
- 7.1.5. Recombinant
- 7.1.6. Conjugate Vaccines
8. Nasal Vaccines Market - By Delivery Method
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
- 8.1.2. Spray
- 8.1.3. Drop
9. Nasal Vaccines Market - By Distribution
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
- 9.1.2. Public
- 9.1.3. Private
10. Nasal Vaccines Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Nasal Vaccines Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Nasal Vaccines Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Nasal Vaccines Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Nasal Vaccines Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Nasal Vaccines Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Nasal Vaccines Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Altimmune Inc.
- 11.2.2. AstraZeneca PLC
- 11.2.3. Bharat Biotech International Limited
- 11.2.4. BioDiem, Inc.
- 11.2.5. CanSino Biopharmaceuticals Inc.
- 11.2.6. GlaxoSmithKline plc
- 11.2.7. Iovance Biotherapeutics, Inc.
- 11.2.8. Meda Pharma GmbH
- 11.2.9. MeDiVac, Inc.
- 11.2.10. Pfizer Inc.
- 11.2.11. Sanofi S.A.
- 11.2.12. Seqirus Holdings Pty Ltd
- 11.2.13. Serum Institute of India Pvt. Ltd.
- 11.2.14. TransBio Inc.
- 11.2.15. Vaxlive Inc.
- 11.2.16. Others
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
Product Code: ANV3027
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Nasal Vaccines Market: Vaccine Type Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Vaccine Type
- TABLE Global Nasal Vaccines Market, by Vaccine Type 2019-2032 (USD Million)
- TABLE Nasal Vaccines Market: Delivery Method Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Delivery Method
- TABLE Global Nasal Vaccines Market, by Delivery Method 2019-2032 (USD Million)
- TABLE Nasal Vaccines Market: Distribution Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Distribution
- TABLE Global Nasal Vaccines Market, by Distribution 2019-2032 (USD Million)
- TABLE Nasal Vaccines Market: Regional snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Nasal Vaccines Market, by Region 2019-2032 (USD Million)
- TABLE North America Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
- TABLE North America Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
- TABLE North America Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
- TABLE North America Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
- TABLE Europe Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
- TABLE Europe Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
- TABLE Europe Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
- TABLE Europe Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
- TABLE Asia Pacific Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
- TABLE Asia Pacific Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
- TABLE Asia Pacific Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
- TABLE Asia Pacific Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
- TABLE Latin America Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
- TABLE Latin America Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
- TABLE Latin America Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
- TABLE Latin America Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
- TABLE Middle East and Africa Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
- TABLE Middle East and Africa Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
- TABLE Middle East and Africa Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
- TABLE Middle East and Africa Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
List of Figures
- FIGURE Nasal Vaccines Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2023
- FIGURE Vaccine Type segment market share analysis, 2023 & 2032
- FIGURE Vaccine Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Delivery Method segment market share analysis, 2023 & 2032
- FIGURE Delivery Method segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Distribution segment market share analysis, 2023 & 2032
- FIGURE Distribution segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Regional segment market share analysis, 2023 & 2032
- FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE North America Nasal Vaccines Market share and leading players, 2023
- FIGURE Europe Nasal Vaccines Market share and leading players, 2023
- FIGURE Asia Pacific Nasal Vaccines Market share and leading players, 2023
- FIGURE Latin America Nasal Vaccines Market share and leading players, 2023
- FIGURE Middle East and Africa Nasal Vaccines Market share and leading players, 2023
- FIGURE North America market share analysis by country, 2023
- FIGURE U.S. Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Canada Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Europe Nasal Vaccines Market share analysis by country, 2023
- FIGURE Germany Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Spain Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Italy Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE France Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE UK Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Russia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Netherlands Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Sweden Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Poland Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of the Europe Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Asia Pacific Nasal Vaccines Market share analysis by country, 2023
- FIGURE India Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE China Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Japan Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE South Korea Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Australia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Thailand Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Indonesia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Philippines Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of APAC Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Latin America Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Latin America Nasal Vaccines Market share analysis by country, 2023
- FIGURE Brazil Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Mexico Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Argentina Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Colombia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of LATAM Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Middle East and Africa Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Middle East and Africa Nasal Vaccines Market share analysis by country, 2023
- FIGURE Saudi Arabia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE United Arab Emirates Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Israel Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Turkey Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Algeria Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Egypt Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of MEA Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.